Search Results - "Cantú‐Rodríguez, O."

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? by Ruiz-Argüelles, G J, Tarin-Arzaga, L C, Gonzalez-Carrillo, M L, Gutierrez-Riveroll, K I, Rangel-Malo, R, Gutiérrez-Aguirre, C H, Cantú-Rodríguez, O G, Gómez-Almaguer, D, Giralt, S

“…A total of 72 patients with Ph-positive CML in first chronic phase were followed during a 6-year period in two different institutions in México. Among them, 22…”
Get full text

PB2347: GLOBAL REPRESENTATION AMONG JOURNAL EDITORS IN HEMATOLOGY: ARE WE DIVERSE, EQUITABLE, AND INCLUSIVE? by Gómez‐De León, A., Noyola‐Pérez, A., Gil‐Flores, L., Ramos‐Barrera, E., Rojas‐Guerrero, E., Martínez‐Espinosa, H., Rodríguez‐González, V., Colunga‐Pedraza, P., Tarín‐Arzaga, L., Cantú‐Rodríguez, O., Gutiérrez‐Aguirre, H., Ruíz‐Argüelles, G., Gómez‐Almaguer, D.

Get full text

No clinically relevant differences between capillary and venous blood cell counts in adult haematological patients using a nonautomated lancet by Herrera-Rojas, M. A., Tarín-Arzaga, L., Gómez-De León, A., Vazquez-Mellado de Larracoechea, A., Jaime-Pérez, J. C., Cantú-Rodríguez, O. G., Gutiérrez-Aguirre, C. H., Salazar-Riojas, R., Valdes-Galvan, M. J., Gómez-Almaguer, D.

Get full text

Outpatient allografting using non-myeloablative conditioning: the Mexican experience by CANTU-RODRIGUEZ, O. G, JAIME-PEREZ, J. C, RUIZ-ARGÜELLES, G. J, GOMEZ-ALMAGUER, D, GUTIERREZ-AGUIRRE, C. H, GONZAHLEZ-LLANO, O, MANCIAS-GUERRA, C, TARIN-ARZAGA, L. C, RUIZ-DELGADO, G. J, SANDOVAL-VILLA, C. C, MARFIL-RIVERA, J, MORALES-TOQUERO, A

“…A group of 132 patients with both malignant and nonmalignant conditions was allografted using the 'Mexican' method of non-ablative conditioning. The…”
Get full text

Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience by Gutierrez-Aguirre, C H, Cantú-Rodríguez, O G, Gonzalez-Llano, O, Salazar-Riojas, R, Martinez-González, O, Jaime-Pérez, J C, Morales-Toquero, A, Tarín-Arzaga, L C, Ruiz-Argüelles, G J, Gómez-Almaguer, D

“…Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective strategy for preventing relapse of acute myelogenous leukemia (AML). We analyzed the…”
Get more information

Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study by GUTIERREZ-AGUIRRE, C. H, GOMEZ-AIMAGUER, D, CANTU-RODRIGUEZ, O. G, GONZALEZ-LIANO, O, JAIME-PEREZ, J. C, HERENA-PEREZ, S, MANZANO, C. A, ESTRADA-GOMEZ, R, GONZALEZ-CARRILLO, M. L, RUIZ-ARGÜELLES, G. J

“…Using non-myeloablative conditioning, allogeneic hematopoietic stem cell transplantation (HSCT) was conducted in 43 ALL patients in a CR2. The median age of…”
Get full text

Exploring bioinformatics tools for graft-versus-host disease risk prediction in hematopoietic cell transplantation: A study conducted at a Mexican center by Moncada-Saucedo, N.K., Mendoza-Ibarra, S., Alvarado-Navarro, D., Salazar-Riojas, R., Colunga-Pedraza, P., Gómez-De León, A., Mancías-Guerra, C., Jaime-Pérez, J.C., Cantú-Rodríguez, O., Gutierrez-Aguirre, H., Morcos-Sandino, M., Gómez-Almaguer, D.

Get full text

Bone Marrow Transplantation in a Child with Hemophagocytic Lymphohistiocytosis Using a Less Toxic Conditioning Regimen by González-Llano, Oscar, Mancı́as-Guerra, Consuelo, Cantú-Rodrı́guez, Olga G, Hernández-Garza, Nora Elsa, Quiroga-Rivera, Aquı́les, Herrera-Garza, José Luis, Jaime-Pérez, José Carlos, Gómez-Almaguer, David

“…Hemophagocytic lymphohistiocytosis (HLH) is a rare non-neoplastic, frequently fatal disease of childhood. HLA-matched bone marrow transplantation (BMT) can…”
Get full text

IMMUNOPHENOTYPIC CHARACTERIZATION OF THE FIRST CD19+ CAR-T CELLS IN MEXICO by Chávez-Estrada, Y., Salazar-Riojas, R., Alvarado-Navarro, D.M., Hernández-Navarro, A.K., Ake-Uc, M.B., Moncada-Saucedo, N.K., Gómez-De León, A., Colunga-Pedraza, P., Jiménez-Antolínez, V., Gutierrez-Aguirre, C., Cantu-Rodriguez, O., Künkel, F., Gómez-Almaguer, D.

“…CAR-T therapy has transformed hematological cancer treatment, but its adoption in low- and middle-income countries is constrained by complex manufacturing…”
Get full text

PSY24 COST OF CARE FOR CHRONIC MYELOID LEUKEMIA (CML) IN PATIENTS EXPERIENCING RESISTANCE AND/OR INTOLERANCE TO IMATINIB FROM THE PUBLIC HEALTH SYSTEM PERSPECTIVE IN MEXICO by Hernández-Rivera, G, Aguayo, Á, Cantu-Rodríguez, O, Cervera, E, Gomez-Almaguer, D, Gutiérrez, H, Lopez-Hernández, M, Martínez, D, Oropeza, P, Rico, E, Donato, BM, Juarez-Garcia, A, Vargas-Valencia, J

Get full text

Preliminary phenotypic characterization of hematopoietic and non-hematopoietic stem cells from stimulated bone marrow without expansion for its use in cellular therapy by Mancias-Guerra, C., Velasco-Ruiz, I., Sanchez-Garcia, S., Huerta-Rangel, R., Mendez-Ramirez, N., Fuentes-Chavez, E., Saucedo-Mancias, L., Gutierrez-Aguirre, C., Cantu-Rodriguez, O., San Miguel-Nuncio, N.

Get full text

Impact of the affordability of novel agents in patients with multiple myeloma: Real‐world data of current clinical practice in Mexico by Tarín‐Arzaga, Luz, Arredondo‐Campos, Daniela, Martínez‐Pacheco, Victor, Martínez‐González, Odra, Ramírez‐López, Alba, Gómez‐De León, Andrés, Gutiérrez‐Aguirre, Cesar Homero, Cantú‐Rodríguez, Olga, Jaime‐Pérez, José Carlos, Gómez‐Almaguer, David

“…BACKGROUND The treatment of multiple myeloma (MM) has become costly and difficult to access for patients living in low‐income to middle‐income countries…”
Get full text

Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease by Cesar Homero Gutiérrez-Aguirre, Olga Graciela Cantú-Rodríguez, Omar David Borjas-Almaguer, Oscar González-Llano, José Carlos Jaime-Pérez, Manuel Solano-Genesta, Miguel Gómez-Guijosa, Consuelo Mancias-Guerra, Luz Tarin, David Gómez-Almaguer

“…Chronic graft-versus-host disease is a common late complication of allogeneic hematopoietic stem cell transplantation. Corticosteroids are the standard initial…”
Get full text

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine‐based conditioning regimen: The Mexican experience by Gómez‐Almaguer, David, Vela‐Ojeda, Jorge, Jaime‐Pérez, José C., Gutiérrez‐Aguirre, César H., Cantú‐Rodríguez, Olga G., Sobrevilla‐Calvo, Pedro, Rivas‐Vera, Silvia, Gómez‐Rangel, J. David, Ruiz‐Argüelles, Guillermo J.

“…We studied the effectiveness of a fludarabine/cyclophosphamide‐based conditioning regimen without anti‐thymocyte globulin in 23 aplastic anemia patients who…”
Get full text

Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia by RUIZ-ARGÜELLES, Guillermo J, GOMEZ-ALMAGUER, David, LOPEZ-MARTINEZ, Briceida, CANTU-RODRIGUEZ, Olga G, JAIME-PEREZ, José C, GONZALEZ-LLANO, Oscar

Get full text

Allogeneic Hematopoietic Stem Cell Transplantation with Non-Myeloablative Conditioning in Patients with Acute Myelogenous Leukemia Eligible for Conventional Allografting: A Prospective Study by Ruiz-Argüelles, Guillermo J, Gómez-Almaguer, David, David-Gomez-Rangel, Jose, Vela-Ojeda, Jorge, Cantú-Rodríguez, Olga G, Jaime-Pérez, José C, González-Llano, Oscar, Herrera-Garza, José L

“…Using a non-myeloablative stem cell trasplantation (NST) program, 25 allografts were prospectively given to 24 patients with acute myelogenous leukemia (AML)…”
Get full text

Platelet aggregation in children with acute lymphoblastic leukemia during induction of remission therapy by Jaime-Pérez, José Carlos, Cantú-Rodrı́guez, Olga Graciela, Herrera-Garza, José Luis, Gómez-Almaguer, David

“…Development of thromboembolytic events is a major complication during induction of remission therapy (IRT) for acute lymphoblastic leukemia (ALL) of childhood…”
Get full text

Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning by RUIZ-ARGÜELLES, Guillermo J, GOMEZ-ALMAGUER, David, VELA-OJEDA, Jorge, MORALES-TOQUERO, Amelia, DAVID-GOMEZ-RANGEL, José, GARCIA-RUIZ-ESPARZA, Miriam A, LOPEZ-MARTINEZ, Briceida, CANTU-RODRIGUEZ, Olga G, GUTIERREZ-AGUIRRE, César H

“…Of a group of 149 patients who underwent allogeneic stem cell transplantation using the "Mexican approach", a nonablative preparative regimen, 49 individuals…”
Get full text

Reduced-intensity stem cell transplantation in children and adolescents: The Mexican experience by Gómez-Almaguer, David, Ruiz-Argüelles, Guillermo J., Tarín-Arzaga, Luz del Carmen, González-Llano, Oscar, Jaime-Pérez, José Carlos, López-Martínez, Briceida, Cantú-Rodríguez, Olga G., Herrera-Garza, José Luis

“…A group of 21 consecutive patients aged 4-20 (median 13) years was prospectively allografted using a reduced intensity preparative regimen. The group included…”
Get full text

Hairy cell leukemia is infrequent in México and has a geographic distribution by RUIZ-ARGÜELLES, G. J, CANTU-RODRIGUEZ, O. G, MERCADO-DIAZ, L, GOMEZ-ALMAGUER, D, CORTES-FRANCO, J, GONGORA-BIACHI, R. A, PIZZUTO, J, RODRIGUEZ-CARRILLO, J, ROMERO-GARCIA, F, TORRE-LOPEZ, E, APREZA-MOLINA, M. G

Get full text